We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · June 26, 2019

Lipid-Lowering Drugs Associated With Lower Risk of Retinopathy and Ophthalmic Interventions in Diabetes

American Journal of Ophthalmology

 

Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Ophthalmology
Lipid-Lowering Medications Are Associated With Lower Risk of Retinopathy and Ophthalmic Interventions Among U.S. Patients With Diabetes
Am J Ophthalmol 2019 Jun 10;[EPub Ahead of Print], D Vail, NF Callaway, CA Ludwig, N Saroj, DM Moshfeghi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading